Hackensack Meridian Health

Running trials

• Recruiting

  Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

  NCT07648264· Phase 3· Source

• Recruiting

  Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma

  NCT07226453· Phase 2· Source

• Recruiting

  Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease

  NCT05799378· Phase 3· Source

• Recruiting

  The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

  NCT05836987· Phase 3· Source

• Recruiting

  Clinical Trial of Approaches to Prostate Cancer Surgery

  NCT05155501· Source

• Recruiting

  A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer

  NCT05570253· Phase 2· Source

• Active, not recruiting

  P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma

  NCT04960579· Phase 1· Source

• Recruiting

  Combination Therapy for the Treatment of Diffuse Midline Gliomas

  NCT05009992· Phase 2· Source

• Active, not recruiting

  A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme

  NCT04762069· Phase 2· Source

• Active, not recruiting

  NOURISH-T+: Promoting Healthy Eating and Exercise Behaviors

  NCT04656496· Source

• Recruiting

  Pancreatic Cancer Early Detection Consortium

  NCT04970056· Source

• Active, not recruiting

  Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields

  NCT04469075· Phase 2· Source

• Recruiting

  Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers

  NCT04410796· Phase 2· Source

• Active, not recruiting

  Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant

  NCT03924401· Phase 2· Source

• Active, not recruiting

  First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma

  NCT03625037· Phase 1/2· Source

• Active, not recruiting

  Escitalopram for Agitation in Alzheimer's Disease

  NCT03108846· Phase 3· Source

• Recruiting

  Cardiogenic Shock Working Group Registry

  NCT04682483· Source

• Active, not recruiting

  A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL)

  NCT03033914· Phase 1/2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers2 recruiting
• Acute lymphoblastic leukaemia1 recruiting
• Atrial fibrillation1 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• Coronary artery disease1 recruiting
• Heart failure1 recruiting
• Lung cancer1 recruiting
• Lupus (SLE)1 recruiting
• Multiple myeloma1 recruiting
• Pancreatic cancer1 recruiting
• Prostate cancer1 recruiting
• Stroke1 recruiting
• Triple-negative breast cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Terminated

  Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer

  NCT04698915· Phase 2· Source

• Completed

  Gut and Intratumoral Microbiome Effect on the Neoadjuvant Chemotherapy-induced Immunosurveillance in Triple Negative Breast Cancer

  NCT03586297· Source